Optimal Research Expands Services with Addition of Austin, TX Facility

Optimal Research, a clinical research site solution provider, has announced the addition of a 40 bed Phase I inpatient facility in Austin, TX. The Austin facility is a highly experienced research site having performed in excess of 200 CNS/Pain trials in addition to studies in other therapeutic areas. The addition supports Optimal's corporate expansion and provides Optimal's clients with inpatient study observation capabilities by trained staff with various monitoring options such as cardiac telemetry and pulse oximetry, PK/PD studies, and gastroenterology studies. The facility is located in close proximity to The University of Texas at Austin campus.

"Building and scaling a high-quality team is a key driver to our continued success and to our ability to offer the best research facilities and staff to companies undertaking drug development," said Stephan Bart, MD, President and Chief Medical Officer, Optimal. "TheAustin facility and the research staff there provide our clients with top-notch experience and unparalleled dedication to patient safety and the advancement of medical research to help us better serve our clients."

The Austin site is a 30,000 square foot facility with surgical suites and capacity to house up to 40 patients for overnight studies.Stephen Daniels, DO, will serve as the Lead Principal Investigator and Medical Director of the site. Dr. Daniels is a noted CNS/Pain Key Opinion Leader and provides over 20 years of clinical research experience and clinical trial leadership.

"Our site is pleased to be joining Optimal Research and looks forward to continuing to contribute to the clinical development needs of pharmaceutical clients worldwide," said Stephen Daniels, DO, Principal Investigator and Medical Director of the Austin, TX site. "We are honored to join such a distinguished group and look forward to continuing our work in acute and chronic pain as well as addressing other therapeutic areas of need."